Search
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID
go.drugbank.com/drugs/DB07986ExperimentalSynonyms: [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE
go.drugbank.com/drugs/DB08202ExperimentalSynonyms: 4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol
go.drugbank.com/drugs/DB02120ExperimentalSynonyms: 6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-TriolO1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose
go.drugbank.com/drugs/DB03406ExperimentalSynonyms: O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID
go.drugbank.com/drugs/DB07329ExperimentalSynonyms: 1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID4'-Methylene-5,8,10-trideazaaminopterin
go.drugbank.com/drugs/DB05616InvestigationalCH-1504 is a an antirheumatic agent that has been shown in vitro to be a nonpolyglutamylatable and nonhydroxylatable antifolate that is more efficiently taken up into cells by the reduced folate carrier
Categories: Heterocyclic Compounds, 2-RingInternational brands: M-TrexFinasteride
go.drugbank.com/drugs/DB01216ApprovedInvestigationalFinasteride is a synthetic 4-azasteroid compound [L10565] and specific inhibitor of steroid Type II 5α-reductase, which is an intracellular enzyme that converts the androgen testosterone into 5α-dihydrotestosterone … It works in a similar fashion as [dutasteride], which is another 5-alpha-reductase inhibitor, by exerting antiandrogenic effects.
Mixtures: Finasteride 0.1% / Minoxidil 7%, Finasteride 0.1% / Minoxidil 5%Categories: 5-alpha Reductase Inhibitors, Cytochrome P-450 Substrates17alpha-methyl-4-hydroxynandrolone
go.drugbank.com/drugs/DB01540ExperimentalIllicit17alpha-methyl-4-hydroxynandrolone is a schedule 3 anabolic steroid.
Synonyms: 17α-Methyl-4-hydroxynandrolone, 4-Hydroxy-19-normethyltestosteroneGlumetinib
go.drugbank.com/drugs/DB15630InvestigationalGlumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
Categories: Heterocyclic Compounds, 1-RingSynonyms: 6-(1-methyl-1h-pyrazol-4-yl)-1-((6-(1-methyl-1h-pyrazol-4-yl)imidazo(1,2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4,3-b)pyridineSofosbuvir
go.drugbank.com/drugs/DB08934ApprovedInvestigationalBoth Canadian and American guidelines list Epclusa as a first line recommendation for all genotypes of HCV [L852, A19626]. … In a joint recommendation published in 2016, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) recommend Sofosbuvir as first line therapy
Mixtures: HARVONI®, EPCLUSA®Categories: P-glycoprotein substrates, Treatments for Hepatitis C